$LAES

Moreira Carlos sold $25K of LAES

Moreira Carlos (Chief Executive Officer) sold 7,005 shares of SEALSQ Corp (LAES) at $3.53 on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Moreira Carlos
Published Jun 3, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 9:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LAES
Neutral
medium confidence
Mentioned
$LAES
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LAESNeutralLow
01

Why it matters

The disclosure updates the insider activity record; however, the transaction is explicitly tied to a pre-arranged 10b5-1 plan, which generally lowers the informational content about near-term company prospects.

02

Market read

This is a same-day insider sale datapoint for LAES; absent other catalysts, it is more likely to be a sentiment/positioning input than a fundamental driver.

03

What to watch

Traders may want to compare this sale to prior Form 4 activity (frequency/size) and whether other insiders or major holders are also trimming.

Relevance 7/10Novelty 6/10Timing: SEC Form 4 filed same day as the 2026-06-03 sale

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for SEALSQ (LAES), reporting an open-market sale by the CEO.

Company-level read

Ticker impact

$LAESNeutralMedium confidence
Context

SEALSQ CEO Moreira Carlos sold 7,005 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-03 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction may be muted given 10b5-1 context.

Evidence & confidence

The filing provides a specific sale price/value and confirms it was executed under a pre-arranged Rule 10b5-1 plan, which typically dampens interpretive impact.

Market effects

Minimal—single-company insider transaction with no stated operational or regulatory change.

Minimal—no cross-border or macro linkage indicated.

Minimal—no global deal, trial, or partnership news referenced.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with periods of higher valuation or risk-off sentiment, potentially pressuring the stock if liquidity is thin.

Key entities

  • SEALSQ Corp

    Company whose CEO disclosed an open-market share sale on SEC Form 4.

  • Moreira Carlos

    SEALSQ CEO/director who sold 7,005 shares at $3.5324/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WKEYLow

WISeKey International Holding Ltd.: WISeKey, SEALSQ and Canton of Jura Sign MoU to Establish a Swiss Post-Quantum Semiconductor and Cybersecurity Center

WISeKey (SIX: WIHN, NASDAQ: WKEY) and its subsidiary SEALSQ (NASDAQ: LAES) signed an MoU with the Canton of Jura to establish a CHF 40-60 million Post-Quantum Semiconductor and Cybersecurity Center in Switzerland, aiming to create 250+ jobs and enhance Swiss technological sovereignty. The center will focus on post-quantum semiconductor technologies, including SEALSQ's QS7001 Quantum Shield, and is expected to be operational within 6 years.

Med

Sealsq Releases 1H 2026 Financial Results

Sealsq Corp. reported a 23.5% narrower net loss of $27.8M (1H 2026) and 131.0% revenue growth to $11.2M, driven by quantum-resistant security chip adoption. North America contributed 50% of sales. FY2026 guidance: $27.0M-$36.0M revenue. Analysts: 5 buys, 1 hold. Gross margin: 48.0%.

$LAESLow

SEALSQ Corp (LAES): Financial results for H1 2026

SEALSQ Corp (LAES) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 SEALSQ Reports H1 2026 Financial and Operational Results Revenue Increases 131% to $11.2 Million; FY2026 Guidance Reaffirmed Cash and Cash Equivalents of $486.1 Million at June 30, 2026, Support Continued R&D, Product Certification and Acquisition Integration Confere